Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Still not time to buy U.S. stocks, says Morgan Stanley, sees 15-20% downside in S&P 500

Published 12/15/2022, 08:18 PM
Updated 12/15/2022, 08:18 PM
© Reuters.

By Senad Karaahmetovic

Morgan Stanley's equity strategists are not ready to declare the all-clear for U.S. equities. Despite 2022 being one of the most challenging years for investors, MS sees more challenges for stocks in the near term.

"This is a time for patience," the strategists wrote in the "2023 Outlook" note sent to Morgan Stanley's clients.

The backbone of this cautious stance is the fact that the Fed's actions need 6-12 months to produce the full economic impact. The strategists say the market might not know the full impact of aggressive hikes "until well into next year."

Echoing the comments about high earnings risk, the consensus for the S&P 500 EPS for 2023 stands at $230. This is extremely high, given that some major indicators point to an 80% chance of a recession.

"Such a scenario fails to account for the likelihood that companies will simultaneously encounter declining volumes and loss of pricing power, ushering in powerful negative operating leverage," the strategists wrote.

Morgan Stanley's S&P 500 EPS projection stands at $195 - significantly below consensus. In line with this estimate, they see a 15-20% retreat from current levels in the S&P 500. The drop in the first half of the year should "be followed by recovery through year-end to a level essentially flat with today."

The Fed pause will weaken the U.S. dollar and "could translate into positive returns in commodities, gold and non-US stocks."

"Emerging markets look particularly interesting, given their relative valuations and overall resilience in the face of China lockdowns, energy and food price inflation, and US dollar strength. Based in part on our expectation for improvement in Chinese growth prospects by next spring, we believe the risk/reward is above average," the strategists added.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.